Jake Remaly

New Jersey

Staff Writer at WebMD

Journalist, Primary Care at Medscape

Newspaper reporter, blog editor, man of mystery

Featured in: Favicon

webmd.com

medscape.com (+2) Favicon

mdedge.com Favicon

the-hospitalist.org Favicon

univadis.com Favicon

tcnjsignal.net Favicon

univadis.es Favicon

ourcommunitynow.com

Articles

O que fazer quando um paciente com câncer avançado não compreende a realidade clínica?

2 weeks ago | portugues.medscape.com | Jake Remaly

A hospitalização de um paciente com câncer nem sempre está diretamente relacionada à neoplasia. No entanto, o médico responsável pela internação pode perceber uma desconexão importante: o paciente recém-admitido não compreende a gravidade de seu prognóstico oncológico. Por um lado, a equipe hospitalar e o próprio paciente podem já dispor de instruções prévias e objetivos de tratamento que orientam o plano de cuidados e o possível uso de medidas paliativas.
Physicians Welcome Testosterone Labeling Changes

1 month ago | medscape.com | Jake Remaly

Products must note that they can increase blood pressure, but boxed warnings about adverse cardiovascular events can be removed, the FDA announced.
HCV Cure Rate Quadruples With Peer-Assisted Telehealth

Jan 29, 2025 | medscape.com | Jake Remaly

Pills can cure infection with the hepatitis C virus (HCV), but getting the medication to patients who need treatment can be a challenge. Many patients with HCV use drugs such as methamphetamine or heroin and were exposed to the virus by sharing needles. Lack of housing, difficulty getting to appointments, and mistrust of the healthcare system are potential barriers to care.
El uso de mascarilla facial durante las inyecciones intravítreas puede tener consecuencias imprevistas

Dec 8, 2024 | univadis.es | Jake Remaly

Editado por Jake RemalyCONCLUSIÓN PRÁCTICAEl uso de mascarilla facial durante las inyecciones intravítreas de anti-VEGF se asoció con una frecuencia similar de endoftalmitis en comparación con la falta de uso de inyecciones, en un amplio estudio retrospectivo.
Winter Depression: How to Make the ‘SAD’ Diagnosis

Nov 25, 2024 | mdedge.com | Jake Remaly

’Tis the season for recognizing seasonal affective disorder (SAD). Just don’t expect to find SAD in diagnostic handbooks. As a memorable term, SAD “stuck in the general public, and to some extent among health professionals,” said Scott Patten, MD, PhD, professor of psychiatry and epidemiology at the University of Calgary in Alberta, Canada.
Weight Loss Interventions Improve Key Features of PCOS

Nov 6, 2024 | mdedge.com | Jake Remaly

TOPLINE:Weight loss interventions using medication or behavioral changes can improve insulin resistance, hormonal markers, and menstrual frequency in women with polycystic ovary syndrome (PCOS), according to a new meta-analysis. Losing weight may not significantly reduce hirsutism or improve quality of life in women with the condition, however. METHODOLOGY:Researchers systematically reviewed randomized controlled trials comparing weight loss interventions to usual care in women with PCOS.
‘Small Increase’ in Breast Cancer With Levonorgestrel IUD?

Oct 28, 2024 | mdedge.com | Jake Remaly

TOPLINE: The use of a levonorgestrel-releasing intrauterine system (LNG-IUS) is associated with an increased risk for breast cancer. An analysis by Danish researchers found 14 extra cases of breast cancer per 10,000 women using this type of an intrauterine device (IUD) vs women not using hormonal contraceptives. METHODOLOGY: The investigators used nationwide registries in Denmark to identify all women aged 15-49 years who were first-time initiators of any LNG-IUS between 2000 and 2019.
Industry Payments to Peer Reviewers Scrutinized at Four Major Medical Journals

Oct 24, 2024 | mdedge.com | Jake Remaly

TOPLINE: More than half of the US peer reviewers for four major medical journals received industry payments between 2020-2022, new research shows. Altogether they received more than $64 million in general, non-research payments, with a median payment per physician of $7614. Research payments — including money paid directly to physicians as well as funds related to research for which a physician was registered as a principal investigator — exceeded $1 billion.
These Patients May Be Less Adherent to nAMD Treatment

Oct 17, 2024 | mdedge.com | Jake Remaly

TOPLINE: — Patients who receive a diagnosis of neovascular age-related macular degeneration (nAMD) from their primary care clinician may be less likely to adhere to treatment than those who receive the diagnosis from a specialist who provides anti–vascular endothelial growth factor (anti-VEGF) therapy, according to global survey results presented at the European Society of Retina Specialists (EURETINA) 2024.
Cannabis Linked to Bulging Eyes in Graves’ Disease

Sep 27, 2024 | mdedge.com | Jake Remaly

TOPLINE:Among patients with autoimmune hyperthyroidism, those who use cannabis are 1.9 times more likely to develop exophthalmos — eyes that appear to bulge from the face — within 1 year of diagnosis, than those who do not use the drug. However, the added risk may wane over time. METHODOLOGY:Researchers analyzed data from TriNetX, an electronic health record platform, for more than 36,000 patients with autoimmune hyperthyroidism between 2003 and 2023.